Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

BRBR vs HIMS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BRBR
BellRing Brands, Inc.

Packaged Foods

Consumer DefensiveNYSE • US
Market Cap$1.22B
5Y Perf.-48.0%
HIMS
Hims & Hers Health, Inc.

Medical - Equipment & Services

HealthcareNYSE • US
Market Cap$6.63B
5Y Perf.+158.4%

BRBR vs HIMS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BRBR logoBRBR
HIMS logoHIMS
IndustryPackaged FoodsMedical - Equipment & Services
Market Cap$1.22B$6.63B
Revenue (TTM)$2.33B$2.35B
Net Income (TTM)$81M$128M
Gross Margin30.2%69.7%
Operating Margin12.6%4.6%
Forward P/E5.5x51.5x
Total Debt$1.11B$1.12B
Cash & Equiv.$89M$229M

BRBR vs HIMSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BRBR
HIMS
StockMay 20May 26Return
BellRing Brands, In… (BRBR)10052.0-48.0%
Hims & Hers Health,… (HIMS)100258.4+158.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: BRBR vs HIMS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BRBR and HIMS are tied at the top with 3 categories each — the right choice depends on your priorities. Hims & Hers Health, Inc. is the stronger pick specifically for growth and revenue expansion and profitability and margin quality. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
BRBR
BellRing Brands, Inc.
The Income Pick

BRBR has the current edge in this matchup, primarily because of its strength in income & stability and sleep-well-at-night.

  • Dividend streak 0 yrs, beta 0.97
  • Lower volatility, beta 0.97, current ratio 2.35x
  • Beta 0.97, current ratio 2.35x
Best for: income & stability and sleep-well-at-night
HIMS
Hims & Hers Health, Inc.
The Growth Play

HIMS is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 59.0%, EPS growth -3.8%, 3Y rev CAGR 64.5%
  • 161.9% 10Y total return vs BRBR's -36.7%
  • 59.0% revenue growth vs BRBR's 16.1%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthHIMS logoHIMS59.0% revenue growth vs BRBR's 16.1%
ValueBRBR logoBRBRLower P/E (5.5x vs 51.5x)
Quality / MarginsHIMS logoHIMS5.5% margin vs BRBR's 3.5%
Stability / SafetyBRBR logoBRBRBeta 0.97 vs HIMS's 2.40
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)HIMS logoHIMS-51.0% vs BRBR's -83.3%
Efficiency (ROA)BRBR logoBRBR8.0% ROA vs HIMS's 6.0%, ROIC 47.3% vs 10.7%

BRBR vs HIMS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BRBRBellRing Brands, Inc.
FY 2025
Shakes and other beverages
81.7%$1.9B
Powders
15.8%$367M
Other Products
2.5%$57M
HIMSHims & Hers Health, Inc.

Segment breakdown not available.

BRBR vs HIMS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLBRBRLAGGINGHIMS

Income & Cash Flow (Last 12 Months)

HIMS leads this category, winning 4 of 6 comparable metrics.

HIMS and BRBR operate at a comparable scale, with $2.3B and $2.3B in trailing revenue. Profitability is closely matched — net margins range from 5.5% (HIMS) to 3.5% (BRBR). On growth, HIMS holds the edge at +28.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricBRBR logoBRBRBellRing Brands, …HIMS logoHIMSHims & Hers Healt…
RevenueTrailing 12 months$2.3B$2.3B
EBITDAEarnings before interest/tax$289M$164M
Net IncomeAfter-tax profit$81M$128M
Free Cash FlowCash after capex$192M$73M
Gross MarginGross profit ÷ Revenue+30.2%+69.7%
Operating MarginEBIT ÷ Revenue+12.6%+4.6%
Net MarginNet income ÷ Revenue+3.5%+5.5%
FCF MarginFCF ÷ Revenue+8.2%+3.1%
Rev. Growth (YoY)Latest quarter vs prior year+1.8%+28.4%
EPS Growth (YoY)Latest quarter vs prior year-35.6%-27.3%
HIMS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

BRBR leads this category, winning 5 of 5 comparable metrics.

At 6.2x trailing earnings, BRBR trades at a 88% valuation discount to HIMS's 50.3x P/E. On an enterprise value basis, BRBR's 6.0x EV/EBITDA is more attractive than HIMS's 42.7x.

MetricBRBR logoBRBRBellRing Brands, …HIMS logoHIMSHims & Hers Healt…
Market CapShares × price$1.2B$6.6B
Enterprise ValueMkt cap + debt − cash$2.2B$7.5B
Trailing P/EPrice ÷ TTM EPS6.22x50.32x
Forward P/EPrice ÷ next-FY EPS est.5.49x51.51x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple5.96x42.68x
Price / SalesMarket cap ÷ Revenue0.52x2.82x
Price / BookPrice ÷ Book value/share12.25x
Price / FCFMarket cap ÷ FCF4.75x89.61x
BRBR leads this category, winning 5 of 5 comparable metrics.

Profitability & Efficiency

BRBR leads this category, winning 5 of 6 comparable metrics.

On the Piotroski fundamental quality scale (0–9), BRBR scores 5/9 vs HIMS's 4/9, reflecting solid financial health.

MetricBRBR logoBRBRBellRing Brands, …HIMS logoHIMSHims & Hers Healt…
ROE (TTM)Return on equity+23.7%
ROA (TTM)Return on assets+8.0%+6.0%
ROICReturn on invested capital+47.3%+10.7%
ROCEReturn on capital employed+55.3%+10.9%
Piotroski ScoreFundamental quality 0–954
Debt / EquityFinancial leverage2.07x
Net DebtTotal debt minus cash$1.0B$892M
Cash & Equiv.Liquid assets$89M$229M
Total DebtShort + long-term debt$1.1B$1.1B
Interest CoverageEBIT ÷ Interest expense2.91x
BRBR leads this category, winning 5 of 6 comparable metrics.

Total Returns (Dividends Reinvested)

HIMS leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in HIMS five years ago would be worth $23,764 today (with dividends reinvested), compared to $4,018 for BRBR. Over the past 12 months, HIMS leads with a -51.0% total return vs BRBR's -83.3%. The 3-year compound annual growth rate (CAGR) favors HIMS at 29.4% vs BRBR's -34.5% — a key indicator of consistent wealth creation.

MetricBRBR logoBRBRBellRing Brands, …HIMS logoHIMSHims & Hers Healt…
YTD ReturnYear-to-date-59.9%-23.2%
1-Year ReturnPast 12 months-83.3%-51.0%
3-Year ReturnCumulative with dividends-71.9%+116.6%
5-Year ReturnCumulative with dividends-59.8%+137.6%
10-Year ReturnCumulative with dividends-36.7%+161.9%
CAGR (3Y)Annualised 3-year return-34.5%+29.4%
HIMS leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — BRBR and HIMS each lead in 1 of 2 comparable metrics.

BRBR is the less volatile stock with a 0.97 beta — it tends to amplify market swings less than HIMS's 2.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HIMS currently trades 36.4% from its 52-week high vs BRBR's 15.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBRBR logoBRBRBellRing Brands, …HIMS logoHIMSHims & Hers Healt…
Beta (5Y)Sensitivity to S&P 5000.97x2.40x
52-Week HighHighest price in past year$67.00$70.43
52-Week LowLowest price in past year$9.21$13.74
% of 52W HighCurrent price vs 52-week peak+15.6%+36.4%
RSI (14)Momentum oscillator 0–10026.354.5
Avg Volume (50D)Average daily shares traded3.6M34.9M
Evenly matched — BRBR and HIMS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates BRBR as "Buy" and HIMS as "Hold". Consensus price targets imply 207.2% upside for BRBR (target: $32) vs 15.6% for HIMS (target: $30).

MetricBRBR logoBRBRBellRing Brands, …HIMS logoHIMSHims & Hers Healt…
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$32.10$29.67
# AnalystsCovering analysts2019
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+39.1%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

HIMS leads in 2 of 6 categories (Income & Cash Flow, Total Returns). BRBR leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.

Best OverallBellRing Brands, Inc. (BRBR)Leads 2 of 6 categories
Loading custom metrics...

BRBR vs HIMS: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is BRBR or HIMS a better buy right now?

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus 16. 1% for BellRing Brands, Inc. (BRBR). BellRing Brands, Inc. (BRBR) offers the better valuation at 6. 2x trailing P/E (5. 5x forward), making it the more compelling value choice. Analysts rate BellRing Brands, Inc. (BRBR) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — BRBR or HIMS?

On trailing P/E, BellRing Brands, Inc.

(BRBR) is the cheapest at 6. 2x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, BellRing Brands, Inc. is actually cheaper at 5. 5x.

03

Which is the better long-term investment — BRBR or HIMS?

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +137. 6%, compared to -59. 8% for BellRing Brands, Inc. (BRBR). Over 10 years, the gap is even starker: HIMS returned +161. 9% versus BRBR's -36. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — BRBR or HIMS?

By beta (market sensitivity over 5 years), BellRing Brands, Inc.

(BRBR) is the lower-risk stock at 0. 97β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 147% more volatile than BRBR relative to the S&P 500.

05

Which is growing faster — BRBR or HIMS?

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus 16. 1% for BellRing Brands, Inc. (BRBR). On earnings-per-share growth, the picture is similar: Hims & Hers Health, Inc. grew EPS -3. 8% year-over-year, compared to -9. 7% for BellRing Brands, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — BRBR or HIMS?

BellRing Brands, Inc.

(BRBR) is the more profitable company, earning 9. 3% net margin versus 5. 5% for Hims & Hers Health, Inc. — meaning it keeps 9. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BRBR leads at 15. 4% versus 5. 2% for HIMS. At the gross margin level — before operating expenses — HIMS leads at 59. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is BRBR or HIMS more undervalued right now?

On forward earnings alone, BellRing Brands, Inc.

(BRBR) trades at 5. 5x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 46. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BRBR: 207. 2% to $32. 10.

08

Which pays a better dividend — BRBR or HIMS?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is BRBR or HIMS better for a retirement portfolio?

For long-horizon retirement investors, BellRing Brands, Inc.

(BRBR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 97)). Hims & Hers Health, Inc. (HIMS) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BRBR: -36. 7%, HIMS: +161. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between BRBR and HIMS?

These companies operate in different sectors (BRBR (Consumer Defensive) and HIMS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

BRBR

Quality Business

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Gross Margin > 18%
Run This Screen
Stocks Like

HIMS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BRBR and HIMS on the metrics below

Revenue Growth>
%
(BRBR: 1.8% · HIMS: 28.4%)
Net Margin>
%
(BRBR: 3.5% · HIMS: 5.5%)
P/E Ratio<
x
(BRBR: 6.2x · HIMS: 50.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.